Zweig F M, Witte H A
Center for Health Policy Research, George Washington University, Washington, DC 20052.
Jt Comm J Qual Improv. 1993 Aug;19(8):342-54. doi: 10.1016/s1070-3241(16)30019-0.
In a far-reaching decision about scientific evidence in federal cases handed down at the very end of the 1992-1993 term, the U.S. Supreme Court implicated medical practice guidelines in indirect, profound, yet highly uncertain ways. In Daubert v Merrell Dow Pharmaceuticals, Inc the Court ruled that judges must actively screen novel scientific evidence to assure both its relevance and its reliability.
在1992 - 1993任期即将结束时做出的一项关于联邦案件中科学证据的影响深远的裁决中，美国最高法院以间接、深刻但高度不确定的方式涉及了医学实践指南。在“道伯特诉美锐尔·陶氏制药公司案”中，最高法院裁定法官必须积极审查新的科学证据，以确保其相关性和可靠性。
